A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides difficile Infection in Individuals 18 Years of Age and Above
Фаза 2 – изследване на ефективността и дозировката
Заболявания:
Recurrence of Clostridioides difficile Infection
Спонсор: AstraZeneca AB
Налично на:
БГ
Обобщение
Trial status: Authorised
Sustained clinical cure (ie, achievement of initial clinical cure + no recurrent C. difficile infection)
First occurrence of recurrent C. difficile infection
Описание
Sustained clinical cure (ie, achievement of initial clinical cure + no recurrent C. difficile infection)
Кой може да участва
Age group: 65+ years, 18-64 years
Gender: Female, Male
Target enrollment: 122 participants
БГ
EN